FONAR Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of FONAR Corporation - FONR

Stock Information for Lisata Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Lisata Therapeutics Inc.

FONAR Shareholder Notice: Kaskela Law Firm Announces Investigation into Proposed FONAR Corp. (NASDAQ: FONR) Buyout and Encourages Investors to Contact the Firm?
Halper Sadeh LLC Encourages FONR, HTBK, DBRG Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages NATH, RAPT, FONR Shareholders to Contact the Firm to Discuss Their Rights
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of FONAR Corporation
Halper Sadeh LLC Encourages PEN, FONR, GDOT Shareholders to Contact the Firm to Discuss Their Rights
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RAPT Therapeutics, Inc. (Nasdaq - RAPT), Penumbra, Inc. (NYSE - PEN), Calavo Growers, Inc. (Nasdaq - CVGW), FONAR Corporation (Nasdaq - FONR)
Kaskela Law Firm Announces Stockholder Investigation into Fairness of Proposed FONAR Corp. (NASDAQ: FONR) Buyout Price; FONAR Investors Encouraged to Contact the Firm 
Halper Sadeh LLC Encourages FONR, OCFC, FFIC Shareholders to Contact the Firm to Discuss Their Rights

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.